ERBB2 and neoplasm: According to a 20% Ki67 IHC cut‐off based on clinical practice 16, the primary tumor series comprised seven luminal A‐like (Ki67 < 20%) and 14 luminal B‐like (Ki67 ≥ 20%) cases; four of the latter were HER2‐positive.